{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:34:44Z","timestamp":1788888884747,"version":"build-2803163510"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>The aims of this study were to evaluate the efficacy of US Food and Drug Administration-approved drugs in genetically engineered pig-to-baboon kidney xenotransplantation and compare the results with those using an anti-CD40 monoclonal antibody (mAb)-based regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      Ten life-supporting kidney transplants were carried out in baboons using \u03b11,3-galactosyltransferase gene-knockout\/CD46 pigs with various other genetic manipulations aimed at controlling coagulation dysregulation. Eight transplants resulted in informative data. Immunosuppressive therapy consisted of induction with antithymocyte globulin and anti-CD20mAb, and maintenance based on either (1) CTLA4-Ig and\/or tacrolimus (+rapamycin or mycophenolate mofetil) (\n                      <jats:italic toggle=\"yes\">GroupA<\/jats:italic>\n                      [US Food and Drug Administration-approved regimens], n = 4) or (2) anti-CD40mAb + rapamycin (\n                      <jats:italic toggle=\"yes\">GroupB<\/jats:italic>\n                      , n = 4). All baboons received corticosteroids, interleukin-6R blockade, and tumor necrosis factor-\u03b1 blockade. Baboons were followed by clinical and laboratory monitoring of kidney function, coagulation, and immune parameters. At euthanasia, morphological and immunohistochemical studies were performed on the kidney grafts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      The median survival in\n                      <jats:italic toggle=\"yes\">GroupB<\/jats:italic>\n                      was 186 days (range 90\u2013260), which was significantly longer than in\n                      <jats:italic toggle=\"yes\">GroupA<\/jats:italic>\n                      ; median 14 days (range 12\u201332) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Only\n                      <jats:italic toggle=\"yes\">GroupA<\/jats:italic>\n                      baboons developed consumptive coagulopathy and the histopathological features of thrombotic microangiopathic glomerulopathy and interstitial arterial vasculitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Recognizing that the pig donors in each group differed in some genetic modifications, these data indicate that maintenance immunosuppression including anti-CD40mAb may be important to prevent pig kidney graft failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002796","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T12:05:43Z","timestamp":1562587543000},"page":"2090-2104","source":"Crossref","is-referenced-by-count":114,"title":["Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens"],"prefix":"10.1097","volume":"103","author":[{"given":"Takayuki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Hara","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Foote","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Animal Resources Program, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaoran","family":"Wang","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."},{"name":"Second Affiliated Hospital, University of South China, Hengyang City, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."},{"name":"Second Affiliated Hospital, University of South China, Hengyang City, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin C.","family":"Klein","sequence":"additional","affiliation":[{"name":"Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik Jan","family":"Schuurman","sequence":"additional","affiliation":[{"name":"Schubiomed Consultancy, Utrecht, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."},{"name":"Department of Cardiothoracic Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."},{"name":"Second Affiliated Hospital, University of South China, Hengyang City, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Joseph","family":"Tector","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."},{"name":"Department of General Surgery and Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ezzelarab","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Lovingood","sequence":"additional","affiliation":[{"name":"Kirklin Clinic Pharmacy, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ayares","sequence":"additional","affiliation":[{"name":"Revivicor, Blacksburg, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin E.","family":"Eckhoff","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.C.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Iwase","sequence":"additional","affiliation":[{"name":"Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.kint.2016.08.035","article-title":"Renal xenotransplantation: experimental progress and clinical prospects.","volume":"91","author":"Wijkstrom","year":"2017","journal-title":"Kidney Int"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/xen.12166","article-title":"Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.","volume":"22","author":"Higginbotham","year":"2015","journal-title":"Xenotransplantation"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1600-6143.2011.03846.x","article-title":"B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months.","volume":"12","author":"Mohiuddin","year":"2012","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1038\/ncomms11138","article-title":"Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft.","volume":"7","author":"Mohiuddin","year":"2016","journal-title":"Nat Commun"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000002977","article-title":"Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival.","volume":"268","author":"Adams","year":"2018","journal-title":"Ann Surg"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/xen.12167","article-title":"Pig-to-baboon heterotopic heart transplantation\u2013exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens.","volume":"22","author":"Iwase","year":"2015","journal-title":"Xenotransplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/xen.12174","article-title":"Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date.","volume":"22","author":"Iwase","year":"2015","journal-title":"Xenotransplantation"},{"key":"R9-20231002","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12293","article-title":"Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.","volume":"24","author":"Iwase","year":"2017","journal-title":"Xenotransplantation"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trim.2018.08.005","article-title":"B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.","volume":"51","author":"Yamamoto","year":"2018","journal-title":"Transpl Immunol"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1681\/ASN.2004121148","article-title":"Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts.","volume":"16","author":"Shimizu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2011040429","article-title":"Pathologic characteristics of transplanted kidney xenografts.","volume":"23","author":"Shimizu","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/01.TP.0000141361.68446.1F","article-title":"Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation.","volume":"78","author":"Mueller","year":"2004","journal-title":"Transplantation"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/xen.12088","article-title":"Are there advantages in the use of specific pathogen-free baboons in pig organ xenotransplantation models?","volume":"21","author":"Zhou","year":"2014","journal-title":"Xenotransplantation"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/TP.0b013e318199c34f","article-title":"The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients.","volume":"87","author":"Ezzelarab","year":"2009","journal-title":"Transplantation"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1600-6143.2010.03147.x","article-title":"Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.","volume":"10","author":"Lin","year":"2010","journal-title":"Am J Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1600-6143.2012.04054.x","article-title":"A novel monoclonal antibody to CD40 prolongs islet allograft survival.","volume":"12","author":"Lowe","year":"2012","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.trim.2015.02.003","article-title":"Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs.","volume":"32","author":"Iwase","year":"2015","journal-title":"Transpl Immunol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/TP.0000000000000042","article-title":"Increased soluble CD154 (CD40 ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies.","volume":"97","author":"Ezzelarab","year":"2014","journal-title":"Transplantation"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1399-3089.2006.00320.x","article-title":"Antibodies directed to pig non-gal antigens in na\u00efve and sensitized baboons.","volume":"13","author":"Ezzelarab","year":"2006","journal-title":"Xenotransplantation"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"e0180768","DOI":"10.1371\/journal.pone.0180768","article-title":"Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.","volume":"12","author":"Gao","year":"2017","journal-title":"PLOS One"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1167\/iovs.10-6947","article-title":"Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs.","volume":"52","author":"Hara","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20231002","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12312","article-title":"The impact of serum incubation time on IgM\/IgG binding to porcine aortic endothelial cells.","volume":"24","author":"Zhang","year":"2017","journal-title":"Xenotransplantation"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.2002.00309.x","article-title":"Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis.","volume":"61","author":"Shimizu","year":"2002","journal-title":"Kidney Int"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/labinvest.3780086","article-title":"Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts.","volume":"80","author":"Shimizu","year":"2000","journal-title":"Lab Invest"},{"issue":"Suppl 22","key":"R26-20231002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-0012.2010.01270.x","article-title":"Histopathology of xenografts in pig to non-human primate discordant xenotransplantation.","volume":"24","author":"Shimizu","year":"2010","journal-title":"Clin Transplant"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/xen.12063","article-title":"Clinicopathological findings in non-human primate recipients of porcine renal xenografts: quantitative and qualitative evaluation of proteinuria.","volume":"20","author":"Pintore","year":"2013","journal-title":"Xenotransplantation"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.LAB.0000017370.74529.89","article-title":"Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine.","volume":"82","author":"Shimizu","year":"2002","journal-title":"Lab Invest"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1399-3089.2007.00406.x","article-title":"Acute gastric dilatation after porcine islet transplantation in a cynomolgus monkey \u2013 case history and review of the literature.","volume":"14","author":"Campanile","year":"2007","journal-title":"Xenotransplantation"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.30802\/AALAS-CM-17-000117","article-title":"Physiologic aspects of pig kidney transplantation in nonhuman primates.","volume":"68","author":"Iwase","year":"2018","journal-title":"Comp Med"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/00007890-200006150-00013","article-title":"High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.","volume":"69","author":"B\u00fchler","year":"2000","journal-title":"Transplantation"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1399-3089.2004.00148.x","article-title":"Initial experience with the human anti-human CD154 monoclonal antibody, ABI793, in pig-to-baboon xenotransplantation.","volume":"11","author":"Knosalla","year":"2004","journal-title":"Xenotransplantation"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm1171","article-title":"Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience.","volume":"11","author":"Kuwaki","year":"2005","journal-title":"Nat Med"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72164","article-title":"Reply to Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.","volume":"6","author":"Kirk","year":"2000","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"R37-20231002","article-title":"Preliminary results of the use of humanized anti-CD154 in human renal allotransplantation [Abstract].","volume":"1","author":"Kirk","year":"2001","journal-title":"Am J Transplant"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2741\/2829","article-title":"Costimulation blockade: towards clinical application.","volume":"13","author":"Weaver","year":"2008","journal-title":"Front Biosci"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/imt.15.1","article-title":"Novel insights into anti-CD40\/CD154 immunotherapy in tolerance.","volume":"7","author":"Pinelli","year":"2015","journal-title":"Immunotherapy"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/xen.12066","article-title":"Role of anti-CD40 antibody-mediated costimulation blockade on non-gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model.","volume":"21","author":"Mohiuddin","year":"2014","journal-title":"Xenotransplantation"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4635","article-title":"The role of genetically engineered pigs in xenotransplantation research.","volume":"238","author":"Cooper","year":"2016","journal-title":"J Pathol"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/xen.12161","article-title":"Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/\u03b24galnt2 genes.","volume":"22","author":"Estrada","year":"2015","journal-title":"Xenotransplantation"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nri3225","article-title":"The role of complement in the early immune response to transplantation.","volume":"12","author":"Sacks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R44-20231002","first-page":"444","article-title":"Renal transplantation in baboons under FK 506.","volume":"106","author":"Todo","year":"1989","journal-title":"Surgery"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/01.tp.0000251387.40499.0f","article-title":"Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival.","volume":"82","author":"Byrne","year":"2006","journal-title":"Transplantation"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1681\/ASN.2008070778","article-title":"IL-6 and TNF-alpha synergistically inhibit allograft acceptance.","volume":"20","author":"Shen","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-6143.2011.03770.x","article-title":"Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance.","volume":"12","author":"Zhao","year":"2012","journal-title":"Am J Transplant"},{"key":"R48-20231002","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12291","article-title":"Human IL-6, IL-17, IL-1beta, and TNF-alpha differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells.","volume":"24","author":"Gao","year":"2017","journal-title":"Xenotransplantation"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (anti-interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients.","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:34:10Z","timestamp":1696210450000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002796","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}